The risk of influenza transmission will be relatively higher due to factors such as large-scale population movement, visiting relatives and friends, and increased gatherings and parties. In order to respond to respiratory infectious diseases such as influenza in winter and spring, the National Health Commission will work with relevant departments to ensure the storage and supply of relevant medicines. Based on the information we have so far, the production, supply and inventory of relevant key drugs are generally normal, and the distribution rate is also within the normal range. According to feedback from medical institutions at all levels, the channels for purchasing medicines are currently unobstructed and key medicines have been stockpiled as planned.
In order to ensure the supply of relevant medicines to medical hong kong telegram data institutions, we have carried out work in three aspects. The first is that departments coordinate to ensure the supply of key medicines. Our commission, together with the Ministry of Industry and Information Technology, Ministry of Commerce, State-owned Assets Supervision and Administration Commission, has conducted research and surveys on production, procurement, circulation, and storage.
Based on analysis of the incidence trends of winter and spring diseases such as influenza, we have strengthened the guarantee of key medicines and guided companies to strengthen production, supply, circulation, and delivery. Second, medical institutions at all levels are required to prepare sufficient medicines for respiratory infectious diseases such as influenza in advance, strengthen the reporting of shortages of key drugs, and verify and match supply and demand in a timely manner.